New MRI techniques aim to spy on brain Tumor's immune defenses
NCT ID NCT07461948
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests three advanced MRI methods to non-invasively look at the immune cells and proteins around glioblastoma tumors. Researchers will compare MRI results with tissue samples from 15 patients scheduled for surgery. The goal is to see if these scans can replace biopsies for understanding why some tumors are harder to treat.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ferumoxytol (contrast agent)
What this could lead to
If successful, this could lead to a non-invasive way to understand why some glioblastomas resist treatment, potentially guiding future therapies.
What could go wrong
This is a small, early-phase study focused on imaging, not treatment. The techniques may not reliably reflect the immune environment, and results may not change patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact